Novartis to acquire eye care company Alcon Inc.

Article

Novartis is set to pay as much as $39 biliion to buy a controlling stake in Alcon, a Houston company that dominates the eye care market.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.